Mutational analysis reveals that isoleucine 563 gates gas diffusion in carbon monoxide dehydrogenase, indicating that oxygen tolerance can be engineered despite reduced substrate affinity.
CO dehydrogenases (CODH) are metalloenzymes that reversibly oxidize CO to CO 2 at a buried NiFe 4 S 4 active site. The substrates, CO and CO 2 , need therefore to be transported through the protein matrix to reach the active site. The most likely pathway for intra‐protein diffusion is the hydrophobic channel identified in the crystal structures. We used site‐directed mutagenesis in an extensive manner to study the role of the highly conserved isoleucine 563 of Thermococcus sp . AM4 CODH2. Certain substitutions significantly change the biochemical properties of the enzyme (K M for CO, catalytic efficiency, product inhibition constant, catalytic bias, …), and increase its resistance to the inhibitor O 2 , showing that isoleucine 563 plays a key role in determining access to the active site. The mutations have the same effects on the rates of binding of CO and O 2 , showing that the two molecules follow the same pathway and are not discriminated by the protein matrix. The I563F mutation decreases the bimolecular rate constant of inhibition by O 2 15‐fold and increases the IC50 20‐fold. This is the strongest improvement in O 2 resistance reported so far, but it comes at the cost of reduced substrate affinity.
No takes yet. Share an insight, caveat, or question.
Opdam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: